This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Hk Pharmaceuticals, Inc., Telik, Inc.. Active years: 2004-2012.
Company Filing History:
Years Active: 2004-2012
Title: Innovations and Contributions of James G. Keck
Introduction
James G. Keck is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of anticancer therapies and gene function determination. With a total of 2 patents, his work has the potential to impact cancer treatment and genetic research.
Latest Patents
James G. Keck's latest patents include innovative methods for enhancing the effectiveness of anticancer therapies. One patent focuses on sensitizing a mammal, particularly humans, to another anticancer therapy by administering a GST-activated anticancer compound. This method aims to ameliorate side effects associated with existing therapies. Another patent involves the use of ribozymes to alter the phenotype of target cells, allowing researchers to determine the function of specific nucleic acids. This approach can be instrumental in high-throughput screens for gene function assignment and identifying therapeutic targets for diseases.
Career Highlights
Throughout his career, James G. Keck has worked with various companies, including Hk Pharmaceuticals, Inc. and Telik, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovative research.
Collaborations
James has collaborated with notable individuals in his field, including Michael M. Wick and Gail L. Brown. These partnerships have likely enhanced his research and development efforts.
Conclusion
James G. Keck's contributions to anticancer therapy and gene function research highlight his innovative spirit and dedication to improving medical science. His patents reflect a commitment to advancing treatment options and understanding genetic mechanisms.